HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 203 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,572,117 | -32.5% | 292,100 | -27.5% | 0.02% | -30.6% |
Q2 2023 | $14,174,532 | +19.3% | 402,800 | +10.7% | 0.04% | +16.1% |
Q1 2023 | $11,881,335 | -48.7% | 363,900 | -13.5% | 0.03% | -52.3% |
Q4 2022 | $23,169,550 | +67.7% | 420,500 | +34.8% | 0.06% | +62.5% |
Q3 2022 | $13,814,000 | +19.5% | 311,900 | +31.6% | 0.04% | +21.2% |
Q2 2022 | $11,558,000 | +42.4% | 237,000 | +42.1% | 0.03% | +50.0% |
Q1 2022 | $8,115,000 | – | 166,800 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |